首页|Amsterdam University Medical Center Reports Findings in Cholangiocarcinoma (Robo tic Versus Open Hepatic Arterial Infusion Pump Placement for Unresectable Intrah epatic Cholangiocarcinoma)
Amsterdam University Medical Center Reports Findings in Cholangiocarcinoma (Robo tic Versus Open Hepatic Arterial Infusion Pump Placement for Unresectable Intrah epatic Cholangiocarcinoma)
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NETL
NSTL
By a News Reporter-Staff News Editor at Robotics & Machine Learning Daily News Daily News-New research on Oncology-Cholangioca rcinoma is the subject of a report. According to news reporting originating in A msterdam, Netherlands, by NewsRx journalists, research stated, "Hepatic arterial infusion pump (HAIP) chemotherapy is an effective treatment for patients with u nresectable intrahepatic cholangiocarcinoma (iCCA). HAIP chemotherapy requires a catheter inserted in the gastroduodenal artery and a subcutaneous pump." The news reporters obtained a quote from the research from Amsterdam University Medical Center, "The catheter can be placed using an open or robotic approach. T his study aimed to compare perioperative outcomes of robotic versus open HAIP pl acement in patients with unresectable iCCA. We analyzed patients with unresectab le iCCA included in the PUMP-II trial from January 2020 to September 2022 underg oing robotic or open HAIP placement at Amsterdam UMC, Erasmus MC, and UMC Utrech t. The primary outcome was time to functional recovery (TTFR). In total, 22 robo tic and 28 open HAIP placements were performed. The median TTFR was 2 days after robotic placement versus 5 days after open HAIP placement (p <0.001). One patient (4.5%) in the robotic group underwent a conver sion to open because of a large bulky tumor leaning on the hilum immobilizing th e liver. Postoperative complications were similar-36% (8/22) after robotic placement versus 39% (11/28) after open placement (p = 1. 000). The median length of hospital stay was shorter in the robotic group-3 vers us 5 days (p <0.001). All 22 robotic patients initiated HA IP chemotherapy post-surgery, i.e. 93% (26/28) in the open group ( p = 0.497). The median time to start HAIP chemotherapy was 14 versus 18 days (p = 0.153)."
AmsterdamNetherlandsEuropeCancerChemotherapyCholangiocarcinomaDrugs and TherapiesEmerging TechnologiesHe alth and MedicineHospitalsInfusion PumpMachine LearningMedical DevicesOncologyRoboticsRobotsSurgery
NETL
NSTL
